CYduct Diagnostics, Inc. (CYDX)

Market Cap	6.50M +391.9%
Revenue (ttm)	344.78K -14.9%
Net Income	136.51K
EPS	n/a
Shares Out	5.24M
PE Ratio	47.61
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	120
Open	1.240
Previous Close	n/a
Day's Range	1.240 - 1.240
52-Week Range	0.200 - 2.900
Beta	-1.54
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About CYduct Diagnostics

CYduct Diagnostics, Inc., a healthcare company, develops, produces, and markets medical devices for the assessment, identification, diagnosis and treatment of breast cancer. The company offers HALO system, a noninvasive device that utilizes proprietary technology to obtain breast fluid; and MammoView, a fiberoptic technology with the ability to view and collect cells and other abnormalities. It also provides women and clinicians with technology that will lead the Intraductal approach to breast cancer and improvement in breast healthcare. The co...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1986
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: CYDX

Financial Performance

In 2011, CYduct Diagnostics's revenue was $328,612, a decrease of -23.48% compared to the previous year's $429,473. Losses were -$503,787, -57.75% less than in 2010.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 10, 2026

Data Sources Report a data error